|
"hsu chiun"的相关文件
显示项目 36-45 / 149 (共15页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目
| 國立臺灣大學 |
2014 |
Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma
|
Ou, Da-Liang; Chang, Chun-Jung; Jeng, Yung-Ming; Lin, Yi-Jang; Lin, Zhong-Zhe; Gandhi, Anita K.; Liao, Sheng-Chieh; Huang, Zi-Ming; Hsu, Chiun; Cheng, Ann-Lii; 鄭永銘; 張純榮; 林宗哲; 鄭安理; 許駿; 歐大諒 |
| 國立臺灣大學 |
2014 |
Vertical blockade of the IGFR-PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivin
|
Ou, Da-Liang; Lee, Bin-Shyun; Lin, Liang-In; Liou, Jun-Yang; Liao, Sheng-Chieh; Hsu, Chiun; Cheng, Ann-Lii; 鄭安理; 許駿; 歐大諒 |
| 國立臺灣大學 |
2014 |
Phase II Multicentered Study of Low-Dose Everolimus plus Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin as First-Line Treatment for Patients with Advanced Gastric Cancer
|
Shen, Ying-Chun; Li, Chung-Pin; Yen, Chia-Jui; Hsu, Chiun; Lin, Yu-Lin; Lin, Zhong-Zhe; Chen, Li-Tzong; Su, Wu-Chou; Chao, Yee; Yeh, Kun-Huei; Cheng, Ann-Lii; 林宗哲; 林育麟; 鄭安理; 許駿; 葉坤輝 |
| 國立臺灣大學 |
2014 |
Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers
|
Kao, Hsiang-Fong; Chen, I-Chun; Hsu, Chiun; Chang, Sin-Yuan; Chien, Shu-Fen; Chen, Yee-Chun; Hu, Fu-Chang; Yang, James Chih-Hsin; Cheng, Ann-Lii; Yeh, Kun-Huei; 楊志新; 高祥豐; 陳怡君; 鄭安理; 許駿; 葉坤輝; 陳宜君 |
| 國立臺灣大學 |
2014 |
The impact of diabetes mellitus on early cervical cancer in Asia: A population-based cohort study
|
Kuo, Hung-Yang; Lin, Zhong-Zhe; Kuo, Raymond Nienchen; Shau, Wen-Yi; Lai, Chiu-Lin; Yang, Yen-Yun; Shao, Yu Yun; Hsu, Chiun; Chang, Wen-Fang; Chang, Ann-Lii; Yang, James Chih-Hsin; Lai, Mei-Shu; 楊志新; 邵幼雲; 賴美淑; 鄭安理; 許駿; 賴秋伶 |
| 國立臺灣大學 |
2014 |
Comparison of Characteristics and Transarterial Chemoembolization Outcomes in Patients with Unresectable Hepatocellular Carcinoma and Different Viral Etiologies
|
Chen, Bang-Bin; Shih, I-Lun; Wu, Chih-Horng; Hsu, Chiun; Chen, Chien-Hung; Shih, Tiffany Ting-Fang; Liu, Kao-Lang; Liang, Po-Chin; 吳志宏; 施庭芳; 陳邦斌; 許駿; 施怡倫; 陳健弘; 劉高郎; 梁博欽 |
| 國立臺灣大學 |
2014 |
Chemotherapy-Induced Hepatitis B Reactivation in Lymphoma Patients With Resolved HBV Infection: A Prospective Study
|
Hsu, Chiun; Tsou, Hsiao-Hui; Lin, Shyh-Jer; Wang, Ming-Chung; Yao, Ming; Hwang, Wen-Li; Kao, Woei-Yau; Chiu, Chang-Fang; Lin, Sheng-Fung; Lin, Johnson; Chang, Cheng-Shyong; Tien, Hwei-Fang; Liu, Tsang-Wu; Chen, Pei-Jer; Cheng, Ann-Lii; 姚明; 鄭安理; 許駿; 田蕙芬; 陳培哲 |
| 國立臺灣大學 |
2014 |
H3K9 Histone Methyltransferase, KMT1E/SETDB1, Cooperates with the SMAD2/3 Pathway to Suppress Lung Cancer Metastasis
|
Wu, Pei-Chun; Lu, Jeng-Wei; Yang, Jer-Yen; Lin, I-Hsuan; Ou, Da-Liang; Lin, Yu-Hsiang; Chou, Kuan-Hsien; Huang, Wen-Feng; Wang, Wan-Ping; Huang, Yih-Leh; Hsu, Chiun; Lin, Liang-In; Lin, Yueh-Min; Shen, C. -K. James; Tzeng, Tsai-Yu; 林亮音; 許駿; 歐大諒 |
| 國立臺灣大學 |
2014 |
Clinicopathological and prognostic significances of EGFR, KRAS and BRAF mutations in biliary tract carcinomas in Taiwan
|
Chang, Yu-Ting; Chang, Ming-Chu; Huang, Kai-Wen; Tung, Chien-Chih; Hsu, Chiun; Wong, Jau-Min; 董建志; 黃凱文; 許駿; 章明珠; 張毓廷 |
| 國立臺灣大學 |
2014 |
Development of GADD45 beta (growth arrest DNA damage-inducible gene 45 beta) agonists for the treatment of hepatocellular carcinoma (HCC)
|
Hsu, Chiun; Ou, Da-Liang; Chen, Kuen-Feng; Lin, Zhong-Zhe; Cheng, Ann-Lii; Shiau, Chung-Wai; 林宗哲; 鄭安理; 許駿; 陳昆鋒; 歐大諒 |
显示项目 36-45 / 149 (共15页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目
|
